1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Migraine Headache Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Almotriptan
        1.2.3 Eletriptan
        1.2.4 Sumatriptan
        1.2.5 Rizatriptan
        1.2.6 Zolmitriptan
        1.2.7 Naratriptan
        1.2.8 Frovatriptan
        1.2.9 Others
    1.3 Market by Application
        1.3.1 Global Migraine Headache Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Acute Migraine
        1.3.3 Common Migraine
        1.3.4 Classic Migraine
        1.3.5 Chronic Migraine
        1.3.6 Other Migraines
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Migraine Headache Drugs Market Perspective (2017-2028)
    2.2 Migraine Headache Drugs Growth Trends by Region
        2.2.1 Migraine Headache Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Migraine Headache Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Migraine Headache Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Migraine Headache Drugs Market Dynamics
        2.3.1 Migraine Headache Drugs Industry Trends
        2.3.2 Migraine Headache Drugs Market Drivers
        2.3.3 Migraine Headache Drugs Market Challenges
        2.3.4 Migraine Headache Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Migraine Headache Drugs Players by Revenue
        3.1.1 Global Top Migraine Headache Drugs Players by Revenue (2017-2022)
        3.1.2 Global Migraine Headache Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Migraine Headache Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Migraine Headache Drugs Revenue
    3.4 Global Migraine Headache Drugs Market Concentration Ratio
        3.4.1 Global Migraine Headache Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Migraine Headache Drugs Revenue in 2021
    3.5 Migraine Headache Drugs Key Players Head office and Area Served
    3.6 Key Players Migraine Headache Drugs Product Solution and Service
    3.7 Date of Enter into Migraine Headache Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Migraine Headache Drugs Breakdown Data by Type
    4.1 Global Migraine Headache Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Migraine Headache Drugs Forecasted Market Size by Type (2023-2028)
5 Migraine Headache Drugs Breakdown Data by Application
    5.1 Global Migraine Headache Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Migraine Headache Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Migraine Headache Drugs Market Size (2017-2028)
    6.2 North America Migraine Headache Drugs Market Size by Type
        6.2.1 North America Migraine Headache Drugs Market Size by Type (2017-2022)
        6.2.2 North America Migraine Headache Drugs Market Size by Type (2023-2028)
        6.2.3 North America Migraine Headache Drugs Market Share by Type (2017-2028)
    6.3 North America Migraine Headache Drugs Market Size by Application
        6.3.1 North America Migraine Headache Drugs Market Size by Application (2017-2022)
        6.3.2 North America Migraine Headache Drugs Market Size by Application (2023-2028)
        6.3.3 North America Migraine Headache Drugs Market Share by Application (2017-2028)
    6.4 North America Migraine Headache Drugs Market Size by Country
        6.4.1 North America Migraine Headache Drugs Market Size by Country (2017-2022)
        6.4.2 North America Migraine Headache Drugs Market Size by Country (2023-2028)
        6.4.3 United States
        6.4.4 Canada
7 Europe
    7.1 Europe Migraine Headache Drugs Market Size (2017-2028)
    7.2 Europe Migraine Headache Drugs Market Size by Type
        7.2.1 Europe Migraine Headache Drugs Market Size by Type (2017-2022)
        7.2.2 Europe Migraine Headache Drugs Market Size by Type (2023-2028)
        7.2.3 Europe Migraine Headache Drugs Market Share by Type (2017-2028)
    7.3 Europe Migraine Headache Drugs Market Size by Application
        7.3.1 Europe Migraine Headache Drugs Market Size by Application (2017-2022)
        7.3.2 Europe Migraine Headache Drugs Market Size by Application (2023-2028)
        7.3.3 Europe Migraine Headache Drugs Market Share by Application (2017-2028)
    7.4 Europe Migraine Headache Drugs Market Size by Country
        7.4.1 Europe Migraine Headache Drugs Market Size by Country (2017-2022)
        7.4.2 Europe Migraine Headache Drugs Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Migraine Headache Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Migraine Headache Drugs Market Size by Type
        8.2.1 Asia-Pacific Migraine Headache Drugs Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Migraine Headache Drugs Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Migraine Headache Drugs Market Share by Type (2017-2028)
    8.3 Asia-Pacific Migraine Headache Drugs Market Size by Application
        8.3.1 Asia-Pacific Migraine Headache Drugs Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Migraine Headache Drugs Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Migraine Headache Drugs Market Share by Application (2017-2028)
    8.4 Asia-Pacific Migraine Headache Drugs Market Size by Region
        8.4.1 Asia-Pacific Migraine Headache Drugs Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Migraine Headache Drugs Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Migraine Headache Drugs Market Size (2017-2028)
    9.2 Latin America Migraine Headache Drugs Market Size by Type
        9.2.1 Latin America Migraine Headache Drugs Market Size by Type (2017-2022)
        9.2.2 Latin America Migraine Headache Drugs Market Size by Type (2023-2028)
        9.2.3 Latin America Migraine Headache Drugs Market Share by Type (2017-2028)
    9.3 Latin America Migraine Headache Drugs Market Size by Application
        9.3.1 Latin America Migraine Headache Drugs Market Size by Application (2017-2022)
        9.3.2 Latin America Migraine Headache Drugs Market Size by Application (2023-2028)
        9.3.3 Latin America Migraine Headache Drugs Market Share by Application (2017-2028)
    9.4 Latin America Migraine Headache Drugs Market Size by Country
        9.4.1 Latin America Migraine Headache Drugs Market Size by Country (2017-2022)
        9.4.2 Latin America Migraine Headache Drugs Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Migraine Headache Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Migraine Headache Drugs Market Size by Type
        10.2.1 Middle East & Africa Migraine Headache Drugs Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Migraine Headache Drugs Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Migraine Headache Drugs Market Share by Type (2017-2028)
    10.3 Middle East & Africa Migraine Headache Drugs Market Size by Application
        10.3.1 Middle East & Africa Migraine Headache Drugs Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Migraine Headache Drugs Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Migraine Headache Drugs Market Share by Application (2017-2028)
    10.4 Middle East & Africa Migraine Headache Drugs Market Size by Country
        10.4.1 Middle East & Africa Migraine Headache Drugs Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Migraine Headache Drugs Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Migraine Headache Drugs Introduction
        11.1.4 Pfizer Revenue in Migraine Headache Drugs Business (2017-2022)
        11.1.5 Pfizer Recent Developments
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Migraine Headache Drugs Introduction
        11.2.4 Novartis Revenue in Migraine Headache Drugs Business (2017-2022)
        11.2.5 Novartis Recent Developments
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Company Details
        11.3.2 Johnson & Johnson Business Overview
        11.3.3 Johnson & Johnson Migraine Headache Drugs Introduction
        11.3.4 Johnson & Johnson Revenue in Migraine Headache Drugs Business (2017-2022)
        11.3.5 Johnson & Johnson Recent Developments
    11.4 GSK
        11.4.1 GSK Company Details
        11.4.2 GSK Business Overview
        11.4.3 GSK Migraine Headache Drugs Introduction
        11.4.4 GSK Revenue in Migraine Headache Drugs Business (2017-2022)
        11.4.5 GSK Recent Developments
    11.5 Merck
        11.5.1 Merck Company Details
        11.5.2 Merck Business Overview
        11.5.3 Merck Migraine Headache Drugs Introduction
        11.5.4 Merck Revenue in Migraine Headache Drugs Business (2017-2022)
        11.5.5 Merck Recent Developments
    11.6 Eli Lilly
        11.6.1 Eli Lilly Company Details
        11.6.2 Eli Lilly Business Overview
        11.6.3 Eli Lilly Migraine Headache Drugs Introduction
        11.6.4 Eli Lilly Revenue in Migraine Headache Drugs Business (2017-2022)
        11.6.5 Eli Lilly Recent Developments
    11.7 Teva
        11.7.1 Teva Company Details
        11.7.2 Teva Business Overview
        11.7.3 Teva Migraine Headache Drugs Introduction
        11.7.4 Teva Revenue in Migraine Headache Drugs Business (2017-2022)
        11.7.5 Teva Recent Developments
    11.8 AstraZeneca
        11.8.1 AstraZeneca Company Details
        11.8.2 AstraZeneca Business Overview
        11.8.3 AstraZeneca Migraine Headache Drugs Introduction
        11.8.4 AstraZeneca Revenue in Migraine Headache Drugs Business (2017-2022)
        11.8.5 AstraZeneca Recent Developments
    11.9 Sun Pharma
        11.9.1 Sun Pharma Company Details
        11.9.2 Sun Pharma Business Overview
        11.9.3 Sun Pharma Migraine Headache Drugs Introduction
        11.9.4 Sun Pharma Revenue in Migraine Headache Drugs Business (2017-2022)
        11.9.5 Sun Pharma Recent Developments
    11.10 Grunenthal
        11.10.1 Grunenthal Company Details
        11.10.2 Grunenthal Business Overview
        11.10.3 Grunenthal Migraine Headache Drugs Introduction
        11.10.4 Grunenthal Revenue in Migraine Headache Drugs Business (2017-2022)
        11.10.5 Grunenthal Recent Developments
    11.11 Endo Pharmaceuticals
        11.11.1 Endo Pharmaceuticals Company Details
        11.11.2 Endo Pharmaceuticals Business Overview
        11.11.3 Endo Pharmaceuticals Migraine Headache Drugs Introduction
        11.11.4 Endo Pharmaceuticals Revenue in Migraine Headache Drugs Business (2017-2022)
        11.11.5 Endo Pharmaceuticals Recent Developments
    11.12 Mylan
        11.12.1 Mylan Company Details
        11.12.2 Mylan Business Overview
        11.12.3 Mylan Migraine Headache Drugs Introduction
        11.12.4 Mylan Revenue in Migraine Headache Drugs Business (2017-2022)
        11.12.5 Mylan Recent Developments
    11.13 Bayer
        11.13.1 Bayer Company Details
        11.13.2 Bayer Business Overview
        11.13.3 Bayer Migraine Headache Drugs Introduction
        11.13.4 Bayer Revenue in Migraine Headache Drugs Business (2017-2022)
        11.13.5 Bayer Recent Developments
    11.14 Amneal Pharmaceuticals
        11.14.1 Amneal Pharmaceuticals Company Details
        11.14.2 Amneal Pharmaceuticals Business Overview
        11.14.3 Amneal Pharmaceuticals Migraine Headache Drugs Introduction
        11.14.4 Amneal Pharmaceuticals Revenue in Migraine Headache Drugs Business (2017-2022)
        11.14.5 Amneal Pharmaceuticals Recent Developments
    11.15 Apotex
        11.15.1 Apotex Company Details
        11.15.2 Apotex Business Overview
        11.15.3 Apotex Migraine Headache Drugs Introduction
        11.15.4 Apotex Revenue in Migraine Headache Drugs Business (2017-2022)
        11.15.5 Apotex Recent Developments
    11.16 Ajanta Pharma
        11.16.1 Ajanta Pharma Company Details
        11.16.2 Ajanta Pharma Business Overview
        11.16.3 Ajanta Pharma Migraine Headache Drugs Introduction
        11.16.4 Ajanta Pharma Revenue in Migraine Headache Drugs Business (2017-2022)
        11.16.5 Ajanta Pharma Recent Developments
    11.17 Allergan
        11.17.1 Allergan Company Details
        11.17.2 Allergan Business Overview
        11.17.3 Allergan Migraine Headache Drugs Introduction
        11.17.4 Allergan Revenue in Migraine Headache Drugs Business (2017-2022)
        11.17.5 Allergan Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Migraine Headache Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Almotriptan
    Table 3. Key Players of Eletriptan
    Table 4. Key Players of Sumatriptan
    Table 5. Key Players of Rizatriptan
    Table 6. Key Players of Zolmitriptan
    Table 7. Key Players of Naratriptan
    Table 8. Key Players of Frovatriptan
    Table 9. Key Players of Others
    Table 10. Global Migraine Headache Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 11. Global Migraine Headache Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 12. Global Migraine Headache Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 13. Global Migraine Headache Drugs Market Share by Region (2017-2022)
    Table 14. Global Migraine Headache Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 15. Global Migraine Headache Drugs Market Share by Region (2023-2028)
    Table 16. Migraine Headache Drugs Market Trends
    Table 17. Migraine Headache Drugs Market Drivers
    Table 18. Migraine Headache Drugs Market Challenges
    Table 19. Migraine Headache Drugs Market Restraints
    Table 20. Global Migraine Headache Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 21. Global Migraine Headache Drugs Revenue Share by Players (2017-2022)
    Table 22. Global Top Migraine Headache Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Headache Drugs as of 2021)
    Table 23. Ranking of Global Top Migraine Headache Drugs Companies by Revenue (US$ Million) in 2021
    Table 24. Global 5 Largest Players Market Share by Migraine Headache Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 25. Key Players Headquarters and Area Served
    Table 26. Key Players Migraine Headache Drugs Product Solution and Service
    Table 27. Date of Enter into Migraine Headache Drugs Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Migraine Headache Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 30. Global Migraine Headache Drugs Revenue Market Share by Type (2017-2022)
    Table 31. Global Migraine Headache Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 32. Global Migraine Headache Drugs Revenue Market Share by Type (2023-2028)
    Table 33. Global Migraine Headache Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 34. Global Migraine Headache Drugs Revenue Share by Application (2017-2022)
    Table 35. Global Migraine Headache Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 36. Global Migraine Headache Drugs Revenue Share by Application (2023-2028)
    Table 37. North America Migraine Headache Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 38. North America Migraine Headache Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 39. North America Migraine Headache Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 40. North America Migraine Headache Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 41. North America Migraine Headache Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 42. North America Migraine Headache Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Europe Migraine Headache Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Europe Migraine Headache Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Europe Migraine Headache Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Europe Migraine Headache Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Europe Migraine Headache Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 48. Europe Migraine Headache Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Migraine Headache Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Migraine Headache Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Asia Pacific Migraine Headache Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Asia Pacific Migraine Headache Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Asia Pacific Migraine Headache Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 54. Asia Pacific Migraine Headache Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 55. Latin America Migraine Headache Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Latin America Migraine Headache Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Latin America Migraine Headache Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Latin America Migraine Headache Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Latin America Migraine Headache Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Latin America Migraine Headache Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Migraine Headache Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Migraine Headache Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 63. Middle East and Africa Migraine Headache Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 64. Middle East and Africa Migraine Headache Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 65. Middle East and Africa Migraine Headache Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 66. Middle East and Africa Migraine Headache Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 67. Pfizer Company Details
    Table 68. Pfizer Business Overview
    Table 69. Pfizer Migraine Headache Drugs Product
    Table 70. Pfizer Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million)
    Table 71. Pfizer Recent Developments
    Table 72. Novartis Company Details
    Table 73. Novartis Business Overview
    Table 74. Novartis Migraine Headache Drugs Product
    Table 75. Novartis Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million)
    Table 76. Novartis Recent Developments
    Table 77. Johnson & Johnson Company Details
    Table 78. Johnson & Johnson Business Overview
    Table 79. Johnson & Johnson Migraine Headache Drugs Product
    Table 80. Johnson & Johnson Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million)
    Table 81. Johnson & Johnson Recent Developments
    Table 82. GSK Company Details
    Table 83. GSK Business Overview
    Table 84. GSK Migraine Headache Drugs Product
    Table 85. GSK Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million)
    Table 86. GSK Recent Developments
    Table 87. Merck Company Details
    Table 88. Merck Business Overview
    Table 89. Merck Migraine Headache Drugs Product
    Table 90. Merck Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million)
    Table 91. Merck Recent Developments
    Table 92. Eli Lilly Company Details
    Table 93. Eli Lilly Business Overview
    Table 94. Eli Lilly Migraine Headache Drugs Product
    Table 95. Eli Lilly Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million)
    Table 96. Eli Lilly Recent Developments
    Table 97. Teva Company Details
    Table 98. Teva Business Overview
    Table 99. Teva Migraine Headache Drugs Product
    Table 100. Teva Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million)
    Table 101. Teva Recent Developments
    Table 102. AstraZeneca Company Details
    Table 103. AstraZeneca Business Overview
    Table 104. AstraZeneca Migraine Headache Drugs Product
    Table 105. AstraZeneca Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million)
    Table 106. AstraZeneca Recent Developments
    Table 107. Sun Pharma Company Details
    Table 108. Sun Pharma Business Overview
    Table 109. Sun Pharma Migraine Headache Drugs Product
    Table 110. Sun Pharma Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million)
    Table 111. Sun Pharma Recent Developments
    Table 112. Grunenthal Company Details
    Table 113. Grunenthal Business Overview
    Table 114. Grunenthal Migraine Headache Drugs Product
    Table 115. Grunenthal Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million)
    Table 116. Grunenthal Recent Developments
    Table 117. Endo Pharmaceuticals Company Details
    Table 118. Endo Pharmaceuticals Business Overview
    Table 119. Endo Pharmaceuticals Migraine Headache Drugs Product
    Table 120. Endo Pharmaceuticals Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million)
    Table 121. Endo Pharmaceuticals Recent Developments
    Table 122. Mylan Company Details
    Table 123. Mylan Business Overview
    Table 124. Mylan Migraine Headache Drugs Product
    Table 125. Mylan Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million)
    Table 126. Mylan Recent Developments
    Table 127. Bayer Company Details
    Table 128. Bayer Business Overview
    Table 129. Bayer Migraine Headache Drugs Product
    Table 130. Bayer Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million)
    Table 131. Bayer Recent Developments
    Table 132. Amneal Pharmaceuticals Company Details
    Table 133. Amneal Pharmaceuticals Business Overview
    Table 134. Amneal Pharmaceuticals Migraine Headache Drugs Product
    Table 135. Amneal Pharmaceuticals Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million)
    Table 136. Amneal Pharmaceuticals Recent Developments
    Table 137. Apotex Company Details
    Table 138. Apotex Business Overview
    Table 139. Apotex Migraine Headache Drugs Product
    Table 140. Apotex Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million)
    Table 141. Apotex Recent Developments
    Table 142. Ajanta Pharma Company Details
    Table 143. Ajanta Pharma Business Overview
    Table 144. Ajanta Pharma Migraine Headache Drugs Product
    Table 145. Ajanta Pharma Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million)
    Table 146. Ajanta Pharma Recent Developments
    Table 147. Allergan Company Details
    Table 148. Allergan Business Overview
    Table 149. Allergan Migraine Headache Drugs Product
    Table 150. Allergan Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million)
    Table 151. Allergan Recent Developments
    Table 152. Research Programs/Design for This Report
    Table 153. Key Data Information from Secondary Sources
    Table 154. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Migraine Headache Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Almotriptan Features
    Figure 3. Eletriptan Features
    Figure 4. Sumatriptan Features
    Figure 5. Rizatriptan Features
    Figure 6. Zolmitriptan Features
    Figure 7. Naratriptan Features
    Figure 8. Frovatriptan Features
    Figure 9. Others Features
    Figure 10. Global Migraine Headache Drugs Market Share by Application: 2021 VS 2028
    Figure 11. Acute Migraine Case Studies
    Figure 12. Common Migraine Case Studies
    Figure 13. Classic Migraine Case Studies
    Figure 14. Chronic Migraine Case Studies
    Figure 15. Other Migraines Case Studies
    Figure 16. Migraine Headache Drugs Report Years Considered
    Figure 17. Global Migraine Headache Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 18. Global Migraine Headache Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 19. Global Migraine Headache Drugs Market Share by Region: 2021 VS 2028
    Figure 20. Global Migraine Headache Drugs Market Share by Players in 2021
    Figure 21. Global Top Migraine Headache Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Headache Drugs as of 2021)
    Figure 22. The Top 10 and 5 Players Market Share by Migraine Headache Drugs Revenue in 2021
    Figure 23. North America Migraine Headache Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. North America Migraine Headache Drugs Market Size Market Share by Type (2017-2028)
    Figure 25. North America Migraine Headache Drugs Market Size Market Share by Application (2017-2028)
    Figure 26. North America Migraine Headache Drugs Market Size Share by Country (2017-2028)
    Figure 27. United States Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Canada Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Europe Migraine Headache Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 30. Europe Migraine Headache Drugs Market Size Market Share by Type (2017-2028)
    Figure 31. Europe Migraine Headache Drugs Market Size Market Share by Application (2017-2028)
    Figure 32. Europe Migraine Headache Drugs Market Size Share by Country (2017-2028)
    Figure 33. Germany Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. France Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. U.K. Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Italy Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Russia Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Nordic Countries Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Asia-Pacific Migraine Headache Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 40. Asia Pacific Migraine Headache Drugs Market Size Market Share by Type (2017-2028)
    Figure 41. Asia Pacific Migraine Headache Drugs Market Size Market Share by Application (2017-2028)
    Figure 42. Asia Pacific Migraine Headache Drugs Market Size Share by Region (2017-2028)
    Figure 43. China Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Japan Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. South Korea Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Southeast Asia Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. India Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Australia Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 49. Latin America Migraine Headache Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Latin America Migraine Headache Drugs Market Size Market Share by Type (2017-2028)
    Figure 51. Latin America Migraine Headache Drugs Market Size Market Share by Application (2017-2028)
    Figure 52. Latin America Migraine Headache Drugs Market Size Share by Country (2017-2028)
    Figure 53. Mexico Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Brazil Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Middle East & Africa Migraine Headache Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 56. Middle East and Africa Migraine Headache Drugs Market Size Market Share by Type (2017-2028)
    Figure 57. Middle East and Africa Migraine Headache Drugs Market Size Market Share by Application (2017-2028)
    Figure 58. Middle East and Africa Migraine Headache Drugs Market Size Share by Country (2017-2028)
    Figure 59. Turkey Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 60. Saudi Arabia Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 61. UAE Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 62. Pfizer Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022)
    Figure 63. Novartis Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022)
    Figure 64. Johnson & Johnson Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022)
    Figure 65. GSK Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022)
    Figure 66. Merck Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022)
    Figure 67. Eli Lilly Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022)
    Figure 68. Teva Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022)
    Figure 69. AstraZeneca Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022)
    Figure 70. Sun Pharma Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022)
    Figure 71. Grunenthal Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022)
    Figure 72. Endo Pharmaceuticals Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022)
    Figure 73. Mylan Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022)
    Figure 74. Bayer Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022)
    Figure 75. Amneal Pharmaceuticals Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022)
    Figure 76. Apotex Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022)
    Figure 77. Ajanta Pharma Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022)
    Figure 78. Allergan Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022)
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed